Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. Curr Rheumatol Rep. 2011 Aug; 13(4):308-16.
View in:
PubMed
subject areas
Abatacept
Abatacept
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antibodies, Monoclonal, Murine-Derived
Clinical Trials, Phase III as Topic
Clinical Trials, Phase III as Topic
Humans
Humans
Hydroxychloroquine
Hydroxychloroquine
Immunoconjugates
Immunoconjugates
Interferon-alpha
Interferon-alpha
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Mycophenolic Acid
Mycophenolic Acid
Rituximab
Rituximab
authors with profiles
Eliza Chakravarty